Voloridge Investment Management LLC raised its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 4.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 609,995 shares of the company's stock after acquiring an additional 27,657 shares during the period. Voloridge Investment Management LLC owned about 0.23% of Ryan Specialty worth $39,137,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in RYAN. Raymond James Financial Inc. bought a new position in shares of Ryan Specialty during the 4th quarter valued at about $94,484,000. Norges Bank bought a new position in Ryan Specialty in the fourth quarter valued at approximately $78,358,000. Millennium Management LLC boosted its holdings in shares of Ryan Specialty by 1,111.4% in the fourth quarter. Millennium Management LLC now owns 1,174,086 shares of the company's stock valued at $75,329,000 after buying an additional 1,077,169 shares during the period. Principal Financial Group Inc. increased its position in shares of Ryan Specialty by 115.2% during the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock worth $117,619,000 after acquiring an additional 981,505 shares in the last quarter. Finally, CIBC Private Wealth Group LLC increased its position in shares of Ryan Specialty by 6,911.0% during the fourth quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company's stock worth $48,036,000 after acquiring an additional 774,718 shares in the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at Ryan Specialty
In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 52.21% of the stock is owned by company insiders.
Analysts Set New Price Targets
Several equities research analysts recently commented on RYAN shares. Keefe, Bruyette & Woods cut their price objective on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Barclays reduced their price objective on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research report on Friday, April 11th. Royal Bank of Canada dropped their target price on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. The Goldman Sachs Group upgraded Ryan Specialty from a "neutral" rating to a "buy" rating and boosted their target price for the company from $74.00 to $81.00 in a research note on Tuesday, May 13th. Finally, Morgan Stanley upped their price target on Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a research report on Monday, May 19th. One analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $75.58.
Get Our Latest Stock Analysis on Ryan Specialty
Ryan Specialty Stock Down 0.0%
Shares of NYSE:RYAN traded down $0.03 during trading on Monday, hitting $68.69. 548,694 shares of the company were exchanged, compared to its average volume of 985,615. Ryan Specialty Holdings, Inc. has a fifty-two week low of $52.34 and a fifty-two week high of $77.16. The stock has a market cap of $18.03 billion, a price-to-earnings ratio of 99.56, a P/E/G ratio of 1.19 and a beta of 0.68. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a fifty day moving average price of $70.10 and a two-hundred day moving average price of $68.77.
Ryan Specialty (NYSE:RYAN - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, meeting the consensus estimate of $0.39. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business had revenue of $690.17 million during the quarter, compared to analysts' expectations of $680.80 million. During the same period last year, the business earned $0.35 earnings per share. The firm's revenue was up 25.0% on a year-over-year basis. As a group, research analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th will be paid a dividend of $0.12 per share. The ex-dividend date is Tuesday, May 13th. This represents a $0.48 annualized dividend and a dividend yield of 0.70%. Ryan Specialty's dividend payout ratio is presently 141.18%.
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Recommended Stories

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.